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Derivatives Allow Single-Molecule Imaging of m-Opioid Receptor
Dimerization
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Abstract: m-Opioid receptors (m-ORs) play a critical role in the
modulation of pain and mediate the effects of the most
powerful analgesic drugs. Despite extensive efforts, it remains
insufficiently understood how m-ORs produce specific effects
in living cells. We developed new fluorescent ligands based on
the m-OR antagonist E-p-nitrocinnamoylamino-dihydrocodei-
none (CACO), that display high affinity, long residence time
and pronounced selectivity. Using these ligands, we achieved
single-molecule imaging of m-ORs on the surface of living cells
at physiological expression levels. Our results reveal a high
heterogeneity in the diffusion of m-ORs, with a relevant
immobile fraction. Using a pair of fluorescent ligands of
different color, we provide evidence that m-ORs interact with
each other to form short-lived homodimers on the plasma
membrane. This approach provides a new strategy to inves-
tigate m-OR pharmacology at single-molecule level.
Introduction
Opioid receptors (ORs) belong to the family A of
rhodopsin-like G protein-coupled receptors and occur in
three major subtypes, m, d and k.[1] They are predominantly
found in the central and peripheral nervous system, where
they modulate transmission and perception of pain. Impor-
tantly, m-ORs mediate most therapeutic effects of opioids,
which are the most powerful, but also most addictive
analgesics known to date.[2] In contrast, k- and d-OR
activation causes weaker analgesia, but has been associated
with less side effects.[3] The effects of opioids on neurons are
mainly mediated by activation of heterotrimeric Gi proteins,
which inhibit cAMP production, while opening G protein-
coupled inward rectifying potassium channels (GIRK) and
closing voltage-dependent N-type Ca2+ channels via Gbg
subunits.[2, 3]
Because of their importance as drug targets, m-ORs have
been intensively investigated both, in vitro and in vivo.[1–4] A
major breakthrough in the field has been the determination of
high-resolution three-dimensional structures of the m-OR in
complex with an antagonist and, later on, with an agonist and
G protein mimetic nanobodies, as well as most recently by
cryo-electron microscopy.[5] These studies have provided
important insights into the mechanisms of ligand binding
and receptor activation, which might pave the way to the
rational design of new analgesics with improved efficacy and
less side effects, such as addiction. Interestingly, in the above
studies m-ORs were found to crystallize as dimers.[5a,b] Largely
based on previous experiments applying resonance energy
transfer methods, these findings support the hypothesis that
m-ORs might form homodimers.[1, 4b,6]However, the nanoscale
organization and dynamics of m-ORs on the surface of living
cells remain largely unknown, mostly due to technical
limitations of conventional methods. These typically include
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the requirement of cell disruption, insufficient spatiotemporal
resolution and/or averaging over thousands or even millions
of receptors.[7]
In an attempt to overcome such limitations, we and others
have developed innovative methods based on single-molecule
microscopy, which allow imaging of individual receptors and
other molecules on the surface of living cells with a temporal
resolution of approximately 28.4 ms and a spatial resolution
of approximately 20 nm, which is at least 10 times below the
best theoretical resolution of conventional fluorescence
microscopy.[8] This approach can provide a highly quantitative
characterization of dynamic events, such as protein-protein
interactions among membrane receptors,[9] even when involv-
ing only a small fraction of the investigated molecules.[9a,c,10]
Here, we present the synthesis and single-molecule
microscopy application of new fluorescent, selective m-OR
ligands to study unmodified receptors in living cells at
physiological expression levels.
Results and Discussion
The structure of the ligands consists of a pharmacologi-
cally active compound, a fluorophore, and a linker (Figure 1).
All three units have been chosen with regard to their
individual and specific characteristics to achieve high affinity
and selectivity as well as optimal optical properties for single-
molecule fluorescence microscopy, for example, high signal-
to-noise ratios and low blinking and bleaching rates.
The pharmacologically active moiety (parent ligand) is
based upon E-p-nitrocinnamoylamino-dihydrocodeinone
(CACO), which had been described to be a potent and
selective m-OR ligand, and to retain such properties upon
conjugation with the small organic fluorophore BODIPY
(EC50= 24.4 nm, d/k> 1000 nm) through a small alkylene
linker.[11] The unlabeled ligand has been described to act as
short-term agonist and long-term antagonist with an IC50
value of 0.46: 0.003 nm for m-OR (d= 4.2: 1.3 nm, k= 19:
2.8 nm). A Kd of 0.52: 0.14 nm was measured by means of
saturation binding experiments with [3H]DAMGO.[12] The
nitrocinnamoyl part of the active compound contains a Mi-
chael acceptor, which potentially forms covalent bonds with
nucleophilic side-chains of amino acids in the m-OR binding
pocket. This has been shown in the m-OR crystal structure for
b-funaltrexamine.[5a]
The pentylene linker connects the pharmacologically
active moiety and the fluorophore. In our probe design, we
incorporated a tetraglycine into the linker, inspired by
previous studies based on GPCR-imaging with fluorescent
ligands, which yielded improved results.[13] Cyanine 3 and 5
(Cy3/5) were chosen as fluorophores because of their
advantageous optical properties which make them particu-
larly suited for single-molecule microscopy, including emis-
sion in the red and near infrared regions of the spectrum,
respectively, as well as high absorption coefficients and
quantum yields.[14]
The synthesis shown in Scheme 1 started with a hetero-
Diels–Alder reaction of thebaine 1 and the intermediately
oxidized N-hydroxycarbamate 11, prepared from the respec-
tive chloroformiate 10.[15] The resulting cycloadduct 2 was
hydrogenated to give dihydrocodeinone 3.[16] A nitrocinna-
moyl moiety was introduced by coupling the C14-amino
group of 3 with the respective activated acid, yielding
compound 4.[17] Subsequent reductive amination of the C-6-
keto group led to compound 5.[11] In a preliminary approach,
we directly used the NHS-activated dyes to couple them to
the newly introduced amino-group. However, these probes
had shown high background and a poor signal-to-noise ratio
in single-molecule microscopy experiments (see Supporting
Information). While an alkylene chain might be sufficient to
bridge pharmacophore and fluorophore and define the
distance between the bulky residues, the tetraglycine moiety
additionally increases the polarity of the compound and
prevents sticking to the plasma membrane (Figure 1). This led
to a major increase in selectivity and reduction of back-
ground. The newly introduced amino group of 5 was coupled
to N-Cbz-protected tetraglycine, yielding compound 6.[17]
After deprotection of Cbz with hydrobromic acid, the free
amine 7 was coupled to the NHS-activated dyes Cy3 and Cy5
to give the desired fluorescent ligands 8 and 9 (Scheme 1).
Saturation binding curves obtained for compound 9
showed its selectivity for m-OR (Figure 2A) in a homogenous
time-resolved FRET (HTRF) assay with HEK293 cells, which
gave optimal results. No significant binding was observed to
the other OR-subtypes (Figure 2A). These findings are in
good agreement with previous binding studies on the parent
compound CACO.[12]
We then tested compounds 8 (Cy3 conjugate) and 9 (Cy5
conjugate) against wild-type m-OR expressed in CHO cells,
which adhere very well to glass-coverslips, resulting in
a particularly flat plasma membrane. Compounds 8 and 9
bound to cell-surface receptors were selectively imaged by
total internal reflection fluorescence microscopy (TIRF),
which illuminates only approximately 200 nm at the interface
between the coverslip and the cells (Figure 2B). CHO cells
devoid of m-OR expression were used as control for unspecific
binding. The results confirmed a highly specific binding of the
compounds to m-ORs, with negligible unspecific binding to
the cells or the coverslip (Figure 2B). This approach also
allowed us to obtain concentration-binding relationships for
Figure 1. Structure of the fluorescent, selective m-opioid receptor
ligands (n=5, o=4).
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both compounds. In these experiments, we incubated CHO
cells with increasing concentrations of either compound 8 or 9
for 20 min and imaged them by TIRF microscopy. The mean
intensities of at least 40 cells per condition were averaged for
each concentration of ligand, which allowed us to estimate
their affinities (KD) (Figure 2C). AKD value of 87: 49 nm for
compound 8 was reached, whereas compound 9 showed
a three-fold lower affinity for m-ORs with an estimated KD
value of 295: 141 nm. The initial affinity of CACO for the m-
OR was reported to be 0.52: 0.14 nm.[12] Intrinsic activity of
compound 8 was determined in an inositol mono phosphate-
accumulation assay for G-protein mediated signaling. In this
assay, the compound acted as a partial agonist (EC50=
190 nm, Emax= 57% of maximal response to morphine), while
it was inactive in the b-arrestin-2 recruitment assay (cf.
Supporting Information). Although chemical modifications
often lead to changes in the pharmacological profiles of small
molecules, both compounds retain high affinity towards m-
OR. A 50% wash resist-
ance of CACO has been
reported in competition
binding experiments with
DAMGO, probably due to
the capability of the 14b-p-
nitrocinnamoylamino-side
chain of CACO to bind
covalently to the m-OR.[12]
Fluorescent probes for sin-
gle-molecule microscopy
not only need to possess
high labeling efficiency, but
ideally, also long residence
time on the receptor. Thus,
intrigued by the possibility
that CACO may bind cova-
lently to m-OR, we investi-
gated if compounds 8 and 9
also retained a high wash
resistance. For this purpose,
we performed washing ex-
periments in CHO cells
transiently treated with ei-
ther compound 8 or 9 for
20 min and imaged by
TIRF microscopy (Fig-
ure 3). During washing, we
observed a slow decrease of
fluorescence intensity, until
it reached a plateau at ap-
proximately 33% and 53%
of the initial values for
compound 8 and 9, respec-
tively. Importantly, these
results indicate that both
fluorescent ligands exhibit
a long residence time on m-
OR, with a fraction of vir-
tually non-dissociating re-
ceptors.
Next, we tested the applicability of the new fluorescent
ligands for single-molecule fluorescence microscopy. Both
compounds showed excellent photophysical properties, giving
rise to easily detectable fluorescent spots in TIRFmicroscopy.
Compound 8 showed slower photobleaching in comparison to
compound 9, consistent with the known photophysical
properties of Cy5 and Cy3, respectively.[18] Therefore, the
Cy3 ligand was used for subsequent single-color experiments.
CHO cells transiently transfected to express wild-type m-OR
at low physiological densities (approximately 0.8 receptors
per mm2) were incubated with a saturating concentration of
compound 8 (1 mm) and imaged by fast TIRF microscopy. The
transfected cells were easily distinguishable from the back-
ground, confirming a highly specific binding (Figure 4A).
Individual m-ORs carrying a fluorescent ligand were detected
and tracked using an automated algorithm.[9a,c,19] A time-
averaged mean square displacement (TAMSD) analysis was
performed, which allowed investigating the diffusion of the
Scheme 1. Synthesis of the fluorescent, m-OR selective ligands 8 and 9.
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receptors within the plasma membrane (cf. Supporting
Information). This analysis revealed a high heterogeneity in
the mobility of m-ORs on the plasma membrane. Individual m-
OR particles were classified into four categories based on the
type and speed of their motion.[9c]A percentage of 22: 2% of
the receptors were virtually immobile, likely due to trapping
in small nanodomains or binding to immobile membrane
structures. Sub-diffusive motion was observed for 34: 1%,
meaning their motion was hindered by either crowding or
interactions with their environment. This phenomenon has
been previously described for other membrane receptors and
can arise from different factors, such as transient trapping in
nanodomains.[9c,20]
Another 34: 1% of the receptors showed normal diffu-
sion, that is, Brownian motion. Super-diffusion, that is,
directional motion, was observed for the remaining 10: 1%
of particles.
These results are in agreement with previous findings for
other prototypical GPCRs like the b2- or the a2A-adrenergic
receptor.[9c]
We then explored the applicability of compounds 8 and 9
in single-molecule microscopy experiments to investigate the
dimerization of m-OR at low/physiological expression levels
in living cells. For this purpose, CHO cells were transiently
transfected with wild-type m-OR, yielding a total receptor
density of around 1.7 particles per mm2. The cells were then
simultaneously labeled with a mixture of compounds 8 and 9
(1 mm and 0.5 mm, respectively) to label as many receptors as
possible (approximately 80%) with either compound, while
keeping unspecific binding to the glass-coverslip low. Then,
imaging by fast two-color TIRF microscopy was carried out.
The co-localization between receptors labeled with com-
pound 8 and 9 was analyzed by automated computer
algorithms as previously described.[9c] In order to correct for
the presence of random co-localizations and to estimate the
duration of m-OR interactions, we applied a previously
developed method based on deconvolution of the co-local-
ization times.[9c] For this purpose, we additionally performed
the same experiment using m-ORs labeled with compound 8
and CD86, a monomeric control protein not interacting with
m-OR, labeled with Alexa Fluor 647 via a SNAP-tag fused at
its N-terminus (Figure S2 in the Supporting Information).[9a]
This served as control for the co-localizations expected in the
absence of interactions. The deconvolution analysis revealed
Figure 2. Characterization of compounds 8 and 9. A) Selectivity of
compound 9 for m-OR versus k-OR and d-OR. HEK293 cells were
transfected with either OR subtype carrying a SNAP-tag at its N-
terminus and labeled with SNAP-Lumi4-Tb. Binding of the fluorescent
ligand was detected via HTRF. The mean : S.E.M. of three independ-
ent experiments is shown. B) Representative TIRF images of CHO cells
either transfected with wild-type m-OR or mock transfected and treated
with increasing concentrations of compound 8. C. Concentration-
binding relationships for compounds 8 and 9 obtained from images as
in B. The mean : S.E.M. of three independent experiments is shown
(32 to 86 cells per data point).
Figure 3. Wash resistance of compounds 8 and 9. A) Representative
TIRF images of CHO cells transiently transfected with wild-type m-OR
and treated with 1 mm of compound 8 (top) or 9 (bottom) for 20 min
followed by washing. The same cells were imaged every minute during
the wash. B) Plots of compound 8/9 dissociation over time obtained
from image sequences as in (A). Photobleaching of compounds 8
during this time was negligible; the intensity values of compound 9
were corrected for photobleaching. The mean : S.E.M. of four
independent experiments is shown (13 and 15 cells per data point,
respectively). Data were fitted with a one phase exponential decay plus
a constant.
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that more than 95% of m-ORs were diffusing on the plasma
membrane as monomers. However, it also revealed a small
but consistent fraction of receptors that apparently under-
went transient interactions lasting approximately 1–2 seconds.
At the low receptor densities analyzed, this fraction of m-ORs
that were interacting at any given time was approximately 4–
5%. Although this represents only a fraction of the receptors,
this value is remarkably similar to the one observed between
active receptors and G proteins,[9c] a fundamental interaction
in GPCR signaling, suggesting that although involving only
a small fraction of receptors it might nevertheless be
biologically relevant. Even though the presence of an even
smaller fraction of higher order oligomers cannot be com-
pletely ruled out, the intensities of the majority of receptor
particles and their bleaching behavior (i.e., number of
observed photobleaching steps) were consistent with them
being monomers or at most dimers. By deconvolving the
distribution of the co-localization times observed between m-
ORs labeled with compounds 8 and 9, and those obtained
between m-OR and CD86, we were able to estimate the
frequency and duration of the interactions between m-ORs.
The resulting relaxation plot of m-OR interactions (Fig-
ure 5B) indicated that m-ORs were dissociating following an
exponential decay, with an estimated time constant (t) of
1.797: 0.487 s (corresponding to a dissociation rate constant,
koff, of 0.557: 0.207 s@1). This value is in good agreement with
previous results obtained with prototypical family A
GPCRs.[9a–c,21] This approach also allowed us to calculate the
two-dimensional association rate (kon) for interactions be-
tween m-ORs, that is, the formation of dimers, which we
estimated to be 0.020: 0.004 mm2molecule@1 s@1. The estimat-
ed kon and koff values give a dissociation equilibrium constant
(Kd) of 27.43: 11.75 molecules per mm2, allowing to predict
the fraction of m-ORs in monomeric or dimeric state depend-
ing on their density on the plasma membrane. Based on the
obtained Kd value, we estimate that a m-OR density of
approximately 27 molecules per mm2 would be required for
50% of them to be in dimeric state (approximately 7 dimers
and 14 monomers per mm2). Since such densities might occur
at synapses,[22] it is possible that a relevant fraction of m-ORs
might form transient dimers in vivo.[23]
Interestingly, the majority of receptors seemed to tran-
siently stop diffusing while interacting (Figure 5A). A
possible explanation for this is that the observed interactions
might represent receptors being simultaneously recruited to
Figure 4. Single-molecule imaging of m-ORs on the surface of living
cells using compound 8. A) Representative results. A frame of a repre-
sentative TIRF image sequence (left) and the results of the automated
single-particle detection (middle) and tracking algorithm used to
follow individual m-ORs (right) is shown. The current position of
individual receptors (blue circles) and their trajectories (green splines)
are shown. B) Time-averaged mean square displacement (TAMSD)
analysis on the obtained m-OR trajectories. Based on the results, the
trajectories were classified into four categories: virtually immobile,
sub-diffusive, normal diffusive and super-diffusive. Shown are exam-
ples of trajectories belonging to the four categories and their corre-
sponding TAMSD curves. C) Distribution of m-ORs trajectories in the
four categories identified by the TAMSD analysis. Data are mean :
S.E.M of 29 individual cells (2,225 trajectories).
Figure 5. Single-molecule imaging of transient m-OR interactions.
A) Example of a transient co-localization (yellow) observed between
two m-ORs, one labeled with compound 8 (green) and the other with
compound 9 (magenta). Both receptors interrupted their motion
during the co-localization event. B) Estimation of the frequency and
duration of interactions between m-ORs based on deconvolution of
their co-localization times with those obtained between m-ORs and
CD86, where no interactions are expected. Data are from 51832 co-
localizations obtained from 25 individual cells for m-OR-m-OR and
61259 co-localizations for CD86-m-OR.
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the same clathrin-coated pit (CCP) before internalization. To
investigate this possibility, we repeated the same experiment
in the presence of co-transfected GFP-tagged clathrin (Fig-
ure 6). Computational analyses showed that 77: 9% of all
observed m-OR interactions happen outside of CCPs, with
only 23: 9% occurring within or near CCPs. These results
suggest that other mechanisms are involved in the observed
transient trapping of m-ORs during their interactions.
Conclusion
Whereas GPCRs have long been believed to be solely
monomeric receptors, a growing body of evidence obtained
mainly using fluorescence and bioluminescence resonance
energy transfer (FRET and BRET) suggests that they might
form dimers or even higher order oligomers.[7, 10b,24] However,
the occurrence of GPCR dimerization at physiological
expression levels and their stability remain—with few notable
exceptions such as family C GPCRs—controversial. These
debates also extend to m-OR, for which contrasting results
have been obtained using methods relying on different
expression levels, ranging from physiological levels to over-
expression and even purification. Whereas several of the
published studies provide evidence in favor of dimeriza-
tion,[1, 4b,5a, 25] others indicate that m-ORs can function as
monomers or the fraction of dimers is negligible.[26] Our data,
obtained on wild-type receptors expressed at levels in living
cells contribute to resolve this controversy by showing that
whereas most m-ORs are monomeric, a small, though
potentially biologically relevant, fraction of receptors under-
go transient dimerization. As the receptors appear to be in
equilibrium between monomers and dimers, higher level of
dimerization might be achieved at sites of particular high
receptor density such as synapses.
In summary, we developed two novel, fluorescent, sub-
type-selective ligands for the m-OR with binding affinities in
the nanomolar range and the advantageous property of wash
resistance. Importantly, we show that the favorable properties
of these ligands make them ideal for single-molecule micros-
copy. We used this set of ligands to investigate the diffusion
behavior of m-ORs as well as their interactions at physio-
logical expression levels. Our results reveal the occurrence of
transient receptor interactions, consistent with a dynamic
equilibrium between monomers and dimers. As only a small
fraction of receptors was found to be interacting with each
other in our study, which is too small to be detected in
ensemble measurements, our results may help to reconcile
some of the apparent discrepancies between previous studies.
Importantly, our results reveal dynamic interactions among m-
ORs that occur outside CCPs that would have likely been
missed using ensemble methods. This new approach opens up
new venues to investigate m-OR biology and pharmacology in
living cells with unprecedented spatiotemporal resolution.
Experimental Section
Comprehensive details of the experimental design can be found
in the Supporting Information.
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